Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation
Open Care announces Immubio platform based on nanoparticle science, currently developing potential break-through COVID-19 immunisation MELBOURNE, Australia, Dec. 17, 2020 /PRNewswire/ -- Open Care (https://open.care) have announced the progress of their early-stage development of their potential COVID-19 Immunisation, ImmubioCV, based on Nanobiologics, a new approach centered on nanoparticles, water coherent domains and ultra dilutions that allows for the preparation of potentially safe, effec...
Gustavo Bracho Kostenloser Wertpapierhandel Marco Stacke Wesley Cooke Contract Research Organisations European Patent Office
Source: finanznachrichten.de